Company intelligence / Profile preview

Hangzhou Zeo-Innov Life Technology

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Hangzhou Zeo-Innov Life Technology specializes in developing and commercializing zeolite-based hemostatic dressings for wound care. Their flagship product, a zeolite hemostatic gauze/dressing, has completed clinical trials, received special approval as an innovative medical device in Zhejiang Province, passed GMP assessment, obtained both Chinese Class II registration and FDA 510(k) clearance. Research from the company has been published in high-impact journals such as Nature Communications and Nature Catalysis.

Therapeutic areas: DermatologyHematology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

Received angel investment from Zhejiang University Innovation Institute; no major pharma partnerships listed.

Beyond the preview

Go deeper on Hangzhou Zeo-Innov Life Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Zeo-Innov Life Technology.

Explore the full profile